Preparing the public recordVerifying sources and arranging the latest updates.
Topic coverage
Public health, health care, medicines, disease prevention, substance use, and health-system policy.
Health Canada has obtained a permanent injunction to stop Canlab Research from illegally selling injectable peptides in Canada. The injunction addresses the illegal sale of these injectable peptides by Canlab Research.
Open recordOntario is investing an additional $4.6 million to increase production of medical isotopes at the McMaster Nuclear Reactor, extending operations and expanding to 24/7. This brings total government investment to $26.9 million, with the aim of tripling the reactor’s production and research capacity to up to 84,000 treatments per year.
Open recordOntario announced a $4.6 million government investment to expand production at the McMaster Nuclear Reactor, increasing the production of custom medical isotopes for cancer treatments. The plan, building on an earlier $18 million investment, will enable 24/7 operations, boost neutron output, grow research capacity by 300%, and support up to 84,000 cancer…
Open recordOntario is investing an additional $4.6 million to expand medical isotope production at the McMaster Nuclear Reactor, increasing total government investment to $26.9 million and boosting capacity by 300%. The goal is to accelerate research, produce up to 84,000 treatments per year, and help double medical isotope production by 2030 through NIICO,…
Open recordOntario is investing an additional $4.6 million to increase production of cancer-fighting medical isotopes at the McMaster Nuclear Reactor, bringing total government investment in the facility to $26.9 million and boosting production and research capacity by 300%. The goal is to double medical isotope production by 2030 and position Ontario as a global…
Open recordHealth Canada obtained a permanent injunction from the Superior Court of Québec on June 11, 2026, preventing Canlab Research and its representatives from manufacturing, testing, distributing, or selling unauthorized injectable peptides in Canada, including advertising them online. The department will monitor compliance and may pursue prosecution or…
Open recordHealth Canada obtained a permanent injunction from the Superior Court of Québec prohibiting Canlab Research and its representatives from manufacturing, testing, distributing, selling, or advertising unauthorized injectable peptides in Canada. The department will monitor compliance and may pursue prosecution or contempt if Canlab fails to comply;…
Open record